NLRP3 and Alzheimer disease: In the APP/PS1 mouse model of AD, knocking out NLRP3 resulted in increased phagocytosis of Aβ, reduction of Aβ pathology, a rescue of LTP deficits and spine alterations, and prevention of behavioral deficits [175].